首页> 外国专利> Substitute pyridine derivatives; pharmaceutical ingredients containing such compounds; and as inhibitors of monophosphate (PDE1) for the treatment of diseases with intracellular pathway disorders of dopamine-D1 receptors, such as Parkinson, Alzheimer's disease, depression, bipolar disease, hypertension, glaucoma

Substitute pyridine derivatives; pharmaceutical ingredients containing such compounds; and as inhibitors of monophosphate (PDE1) for the treatment of diseases with intracellular pathway disorders of dopamine-D1 receptors, such as Parkinson, Alzheimer's disease, depression, bipolar disease, hypertension, glaucoma

机译:取代吡啶衍生物;含有此类化合物的药物成分;以及作为一磷酸酯(PDE1)抑制剂用于治疗多巴胺D1受体细胞内通路疾病的疾病,例如帕金森氏症,阿尔茨海默氏病,抑郁症,双相性疾病,高血压,青光眼

摘要

Compounds derived from pirimidinonas optionally substituted; Pharmaceutical composition that comprises; and their use to treat diseases such as Parkinson's, Alzheimer's, depressionBipolar disease, hypertension, glaucoma, among others.
机译:衍生自嘧啶酮的化合物,其任选被取代;药物组合物,其包含;及其用于治疗帕金森氏症,阿尔茨海默氏症,抑郁症躁郁症,高血压,青光眼等疾病。

著录项

  • 公开/公告号CL2011001263A1

    专利类型

  • 公开/公告日2011-11-18

    原文格式PDF

  • 申请/专利权人 INTRA-CELLULAR THERAPIES INC.;

    申请/专利号CL20110001263

  • 发明设计人 LI PENG WENNOGLE LAWRENCE P.;

    申请日2011-05-30

  • 分类号A61K31/519;A61P25/00;A61P9/12;C07D487/14;C07D487/16;

  • 国家 CL

  • 入库时间 2022-08-21 17:25:21

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号